Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt 98.65
NYSE:MED's Cash-to-Debt is ranked higher than
76% of the 845 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.91 vs. NYSE:MED: 98.65 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:MED' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1  Med: 1.01 Max: 306.43
Current: 98.65
0.1
306.43
Equity-to-Asset 0.79
NYSE:MED's Equity-to-Asset is ranked higher than
90% of the 831 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.48 vs. NYSE:MED: 0.79 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:MED' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.1  Med: 0.71 Max: 0.79
Current: 0.79
-0.1
0.79
Interest Coverage N/A
NYSE:MED's Interest Coverage is ranked higher than
86% of the 806 Companies
in the Global Specialty Retail industry.

( Industry Median: 25.99 vs. NYSE:MED: N/A )
Ranked among companies with meaningful Interest Coverage only.
NYSE:MED' s Interest Coverage Range Over the Past 10 Years
Min: 14.77  Med: 5142.03 Max: No Debt
Current: N/A
Piotroski F-Score: 7
Altman Z-Score: 17.09
Beneish M-Score: -3.05
WACC vs ROIC
6.29%
104.21%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 9.78
NYSE:MED's Operating Margin % is ranked higher than
80% of the 844 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.21 vs. NYSE:MED: 9.78 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:MED' s Operating Margin % Range Over the Past 10 Years
Min: 6.82  Med: 10.15 Max: 12.28
Current: 9.78
6.82
12.28
Net Margin % 6.50
NYSE:MED's Net Margin % is ranked higher than
80% of the 843 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.91 vs. NYSE:MED: 6.50 )
Ranked among companies with meaningful Net Margin % only.
NYSE:MED' s Net Margin % Range Over the Past 10 Years
Min: 4.58  Med: 6.36 Max: 7.61
Current: 6.5
4.58
7.61
ROE % 19.36
NYSE:MED's ROE % is ranked higher than
84% of the 823 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.54 vs. NYSE:MED: 19.36 )
Ranked among companies with meaningful ROE % only.
NYSE:MED' s ROE % Range Over the Past 10 Years
Min: 12.72  Med: 21.54 Max: 32.75
Current: 19.36
12.72
32.75
ROA % 14.91
NYSE:MED's ROA % is ranked higher than
92% of the 848 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.54 vs. NYSE:MED: 14.91 )
Ranked among companies with meaningful ROA % only.
NYSE:MED' s ROA % Range Over the Past 10 Years
Min: 9.54  Med: 16.16 Max: 24.98
Current: 14.91
9.54
24.98
ROC (Joel Greenblatt) % 115.67
NYSE:MED's ROC (Joel Greenblatt) % is ranked higher than
95% of the 846 Companies
in the Global Specialty Retail industry.

( Industry Median: 11.40 vs. NYSE:MED: 115.67 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:MED' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.47  Med: 71.21 Max: 115.67
Current: 115.67
24.47
115.67
3-Year Revenue Growth Rate -0.70
NYSE:MED's 3-Year Revenue Growth Rate is ranked lower than
61% of the 770 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.10 vs. NYSE:MED: -0.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:MED' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -45.9  Med: 28 Max: 63.7
Current: -0.7
-45.9
63.7
3-Year EBITDA Growth Rate -6.90
NYSE:MED's 3-Year EBITDA Growth Rate is ranked higher than
54% of the 647 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.80 vs. NYSE:MED: -6.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:MED' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -6.9  Med: 24.2 Max: 78.5
Current: -6.9
-6.9
78.5
3-Year EPS without NRI Growth Rate -8.70
NYSE:MED's 3-Year EPS without NRI Growth Rate is ranked higher than
59% of the 583 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.80 vs. NYSE:MED: -8.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:MED' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -14.1  Med: 20.85 Max: 68.9
Current: -8.7
-14.1
68.9
GuruFocus has detected 3 Warning Signs with Medifast Inc $NYSE:MED.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:MED's 10-Y Financials

Financials (Next Earnings Date: 2017-06-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MED Guru Trades in Q1 2016

Paul Tudor Jones 16,900 sh (New)
Jim Simons 827,900 sh (+10.93%)
Barrow, Hanley, Mewhinney & Strauss 70,347 sh (-22.17%)
» More
Q2 2016

MED Guru Trades in Q2 2016

Paul Tudor Jones 25,100 sh (+48.52%)
Jim Simons 953,600 sh (+15.18%)
Barrow, Hanley, Mewhinney & Strauss 70,329 sh (-0.03%)
» More
Q3 2016

MED Guru Trades in Q3 2016

Barrow, Hanley, Mewhinney & Strauss Sold Out
Jim Simons 947,200 sh (-0.67%)
Paul Tudor Jones 5,722 sh (-77.20%)
» More
Q4 2016

MED Guru Trades in Q4 2016

Paul Tudor Jones 9,300 sh (+62.53%)
Jim Simons 951,500 sh (+0.45%)
» More
» Details

Insider Trades

Latest Guru Trades with MED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Apparel & Specialty » Specialty Retail    NAICS: 445299    SIC: 2099
Compare:NAS:FTD, NAS:WINA, NYSE:JMEI, NYSE:VSI, NYSE:BNED, NYSE:XOXO, NYSE:PIR, NAS:OSTK, NYSE:HZO, NAS:ZUMZ, NAS:LE, NAS:HIBB, OTCPK:VTNL, NAS:FLWS, NYSE:BKS, NAS:PCMI, NAS:BGFV, NAS:FINL, NYSE:SYX, OTCPK:OMNT » details
Traded in other countries:MDF.Germany,
Medifast Inc is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins.

Medifast Inc is a Delaware Corporation, incorporated in 1993. The Company is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins. Its products and services are sold to weight loss program participants via the Internet, telephone, and brick and mortar clinics. It operates in two reportable segments; Medifast, and MWCC and Wholesale. The Medifast segment consists of the sales from Medifast Direct Marketing and Take Shape For Life. The MWCC and Wholesale segment consists of the sales of Medifast Corporate and Franchise Weight Control Centers as well as Medifast Wholesale Physicians and international sales. Medifast Weight Control Centers is the brick and mortar clinic channel of the Company with affiliate-owned locations in Pennsylvania, New Jersey, Delaware, Texas, Florida, Maryland, North Carolina and Virginia. Medifast Weight Control Centers offer a high-touch model including comprehensive Companys programs for weight loss and maintenance, customized client counseling, an InBody body composition analysis, and monitoring with a BodyGem indirect calorimeter that determines resting metabolic rates. In the direct-to-consumer channel, Medifast Direct, customers order its product directly through the Companys website, www.medifast1.com or its in-house call center. Take Shape For Life is the personal coaching division of the Company. It enriches lives by providing clinically proven weight loss and weight management products and programs. It offers clinically proven products and programs for weight management, weight maintenance, and long-term health through multiple channels of distribution. It offers a variety of weight loss and weight management products under the Medifast and Essential 1 brands and for select private label customers. Its line includes more than 75 options, including, but not limited to bars, bites, pretzels, puffs, cereal crunch, drinks, eggs, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company continues to build and leverage its core brand through multiple marketing strategies for each of its distinct distribution channels such as Medifast Direct, Medical Wholesale, Medifast Weight Control Centers, and Take Shape For Life to their target audiences. It has also developed a comprehensive social media utilizing Facebook, Twitter, YouTube, blogger endorsements, and more. The Company competes with NutriSystem Inc., Herbalife Ltd., USANA Health Sciences, and Weight Watchers International, Inc. The formulation, processing, packaging, and labeling of the Company's products is subject to regulation by several federal agencies, but principally by the FDA.

Ratios

vs
industry
vs
history
PE Ratio 28.77
MED's PE Ratio is ranked lower than
68% of the 822 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.97 vs. MED: 28.77 )
Ranked among companies with meaningful PE Ratio only.
MED' s PE Ratio Range Over the Past 10 Years
Min: 8.97  Med: 20.88 Max: 61.23
Current: 28.77
8.97
61.23
PE Ratio without NRI 28.77
MED's PE Ratio without NRI is ranked lower than
69% of the 766 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.48 vs. MED: 28.77 )
Ranked among companies with meaningful PE Ratio without NRI only.
MED' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.97  Med: 19.36 Max: 61.23
Current: 28.77
8.97
61.23
Price-to-Owner-Earnings 49.77
MED's Price-to-Owner-Earnings is ranked lower than
77% of the 437 Companies
in the Global Specialty Retail industry.

( Industry Median: 19.07 vs. MED: 49.77 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MED' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.61  Med: 22.32 Max: 201.3
Current: 49.77
7.61
201.3
PB Ratio 5.33
MED's PB Ratio is ranked lower than
85% of the 929 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.69 vs. MED: 5.33 )
Ranked among companies with meaningful PB Ratio only.
MED' s PB Ratio Range Over the Past 10 Years
Min: 1.36  Med: 4.03 Max: 10.94
Current: 5.33
1.36
10.94
PS Ratio 1.88
MED's PS Ratio is ranked lower than
76% of the 913 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.68 vs. MED: 1.88 )
Ranked among companies with meaningful PS Ratio only.
MED' s PS Ratio Range Over the Past 10 Years
Min: 0.49  Med: 1.3 Max: 4.73
Current: 1.88
0.49
4.73
Price-to-Free-Cash-Flow 22.88
MED's Price-to-Free-Cash-Flow is ranked lower than
59% of the 429 Companies
in the Global Specialty Retail industry.

( Industry Median: 16.78 vs. MED: 22.88 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MED' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.42  Med: 15.87 Max: 139.65
Current: 22.88
8.42
139.65
Price-to-Operating-Cash-Flow 20.27
MED's Price-to-Operating-Cash-Flow is ranked lower than
72% of the 545 Companies
in the Global Specialty Retail industry.

( Industry Median: 10.64 vs. MED: 20.27 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MED' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.44  Med: 12.54 Max: 51.95
Current: 20.27
5.44
51.95
EV-to-EBIT 16.30
MED's EV-to-EBIT is ranked lower than
54% of the 762 Companies
in the Global Specialty Retail industry.

( Industry Median: 15.04 vs. MED: 16.30 )
Ranked among companies with meaningful EV-to-EBIT only.
MED' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.8  Med: 11.5 Max: 38.8
Current: 16.3
4.8
38.8
EV-to-EBITDA 13.56
MED's EV-to-EBITDA is ranked lower than
59% of the 806 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.04 vs. MED: 13.56 )
Ranked among companies with meaningful EV-to-EBITDA only.
MED' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.9  Med: 8.7 Max: 29.4
Current: 13.56
3.9
29.4
PEG Ratio 15.16
MED's PEG Ratio is ranked lower than
81% of the 298 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.18 vs. MED: 15.16 )
Ranked among companies with meaningful PEG Ratio only.
MED' s PEG Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.8 Max: 15.16
Current: 15.16
0.22
15.16
Shiller PE Ratio 36.95
MED's Shiller PE Ratio is ranked lower than
74% of the 249 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.92 vs. MED: 36.95 )
Ranked among companies with meaningful Shiller PE Ratio only.
MED' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.68  Med: 34.86 Max: 106.67
Current: 36.95
21.68
106.67
Current Ratio 4.15
MED's Current Ratio is ranked higher than
91% of the 793 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.53 vs. MED: 4.15 )
Ranked among companies with meaningful Current Ratio only.
MED' s Current Ratio Range Over the Past 10 Years
Min: 0.58  Med: 3.12 Max: 4.63
Current: 4.15
0.58
4.63
Quick Ratio 3.40
MED's Quick Ratio is ranked higher than
94% of the 792 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.82 vs. MED: 3.40 )
Ranked among companies with meaningful Quick Ratio only.
MED' s Quick Ratio Range Over the Past 10 Years
Min: 0.27  Med: 2.23 Max: 3.47
Current: 3.4
0.27
3.47
Days Inventory 75.54
MED's Days Inventory is ranked higher than
58% of the 792 Companies
in the Global Specialty Retail industry.

( Industry Median: 91.88 vs. MED: 75.54 )
Ranked among companies with meaningful Days Inventory only.
MED' s Days Inventory Range Over the Past 10 Years
Min: 74.24  Med: 88.15 Max: 165.97
Current: 75.54
74.24
165.97
Days Sales Outstanding 1.84
MED's Days Sales Outstanding is ranked higher than
88% of the 635 Companies
in the Global Specialty Retail industry.

( Industry Median: 13.84 vs. MED: 1.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
MED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.88  Med: 1.83 Max: 2.46
Current: 1.84
0.88
2.46
Days Payable 50.77
MED's Days Payable is ranked lower than
99.99% of the 591 Companies
in the Global Specialty Retail industry.

( Industry Median: 53.84 vs. MED: 50.77 )
Ranked among companies with meaningful Days Payable only.
MED' s Days Payable Range Over the Past 10 Years
Min: 50.77  Med: 57.99 Max: 73.92
Current: 50.77
50.77
73.92

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.65
MED's Dividend Yield % is ranked higher than
55% of the 959 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.28 vs. MED: 2.65 )
Ranked among companies with meaningful Dividend Yield % only.
MED' s Dividend Yield % Range Over the Past 10 Years
Min: 0.81  Med: 2.24 Max: 2.77
Current: 2.65
0.81
2.77
Dividend Payout Ratio 0.72
MED's Dividend Payout Ratio is ranked lower than
72% of the 559 Companies
in the Global Specialty Retail industry.

( Industry Median: 9999.00 vs. MED: 0.72 )
Ranked among companies with meaningful Dividend Payout Ratio only.
MED' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.44 Max: 0.72
Current: 0.72
0.15
0.72
Forward Dividend Yield % 2.96
MED's Forward Dividend Yield % is ranked higher than
61% of the 944 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.45 vs. MED: 2.96 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.65
MED's 5-Year Yield-on-Cost % is ranked lower than
53% of the 1179 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.66 vs. MED: 2.65 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
MED' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.81  Med: 2.24 Max: 2.77
Current: 2.65
0.81
2.77
3-Year Average Share Buyback Ratio 3.30
MED's 3-Year Average Share Buyback Ratio is ranked higher than
93% of the 494 Companies
in the Global Specialty Retail industry.

( Industry Median: -0.40 vs. MED: 3.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MED' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -20.4  Med: -4.5 Max: 8
Current: 3.3
-20.4
8

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 9.92
MED's Price-to-Net-Cash is ranked higher than
57% of the 112 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.00 vs. MED: 9.92 )
Ranked among companies with meaningful Price-to-Net-Cash only.
MED' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 9.07  Med: 20.67 Max: 382.25
Current: 9.92
9.07
382.25
Price-to-Net-Current-Asset-Value 6.73
MED's Price-to-Net-Current-Asset-Value is ranked lower than
59% of the 482 Companies
in the Global Specialty Retail industry.

( Industry Median: 4.60 vs. MED: 6.73 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
MED' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 5.94  Med: 11.35 Max: 35.25
Current: 6.73
5.94
35.25
Price-to-Tangible-Book 5.33
MED's Price-to-Tangible-Book is ranked lower than
77% of the 840 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.09 vs. MED: 5.33 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MED' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.27  Med: 4.05 Max: 12.33
Current: 5.33
1.27
12.33
Price-to-Intrinsic-Value-Projected-FCF 1.63
MED's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
62% of the 514 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.29 vs. MED: 1.63 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MED' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.01  Med: 3.32 Max: 11.22
Current: 1.63
1.01
11.22
Price-to-Median-PS-Value 1.44
MED's Price-to-Median-PS-Value is ranked lower than
77% of the 771 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.05 vs. MED: 1.44 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MED' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.13  Med: 1.04 Max: 4.72
Current: 1.44
0.13
4.72
Price-to-Graham-Number 2.61
MED's Price-to-Graham-Number is ranked lower than
71% of the 595 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.59 vs. MED: 2.61 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MED' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.31  Med: 1.93 Max: 5.92
Current: 2.61
0.31
5.92
Earnings Yield (Greenblatt) % 6.14
MED's Earnings Yield (Greenblatt) % is ranked higher than
57% of the 934 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.23 vs. MED: 6.14 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MED' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.6  Med: 8.7 Max: 20.7
Current: 6.14
2.6
20.7
Forward Rate of Return (Yacktman) % 7.21
MED's Forward Rate of Return (Yacktman) % is ranked higher than
58% of the 539 Companies
in the Global Specialty Retail industry.

( Industry Median: 4.06 vs. MED: 7.21 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MED' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.9  Med: 27.7 Max: 47.3
Current: 7.21
6.9
47.3

More Statistics

Revenue (TTM) (Mil) $274.5
EPS (TTM) $ 1.50
Beta0.51
Short Percentage of Float4.34%
52-Week Range $28.30 - 46.36
Shares Outstanding (Mil)11.91
» More Articles for NYSE:MED

Headlines

Articles On GuruFocus.com
Piotroski F-Score Study: Specialty Retail Companies Offer Hot Buys Jul 06 2016 
Insiders Roundup: Buys of Advance Auto Parts, Sales of Fitbit Jun 03 2016 
Director Boosts Stake in Sears as Retail Companies Become Hot Buys Jun 02 2016 
Guru Stocks With Strong 10-Year Returns May 12 2016 
NutriSystem Stock Surges On Upbeat Q4 2014 Results Mar 04 2015 
This Company Focuses on Consumer Preferences in the Entire World Dec 17 2014 
Is It Time to Buy Avon? Dec 11 2014 
Small cap high short interest (Predictability = 5), Part 1 Oct 16 2014 
Should You Stay Away From Avon? Sep 30 2014 
How Are GuruFocus Model Portfolios Faring Beside the Market in 2012? Dec 28 2012 

More From Other Websites
MEDIFAST INC Financials Mar 23 2017
Medifast, Inc. breached its 50 day moving average in a Bullish Manner : MED-US : March 23, 2017 Mar 23 2017
Medifast, Inc. : MED-US: Dividend Analysis : March 23rd, 2017 (record date) : By the numbers : March... Mar 22 2017
Medifast, Inc. :MED-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
MEDIFAST INC Files SEC form 10-K, Annual Report Mar 16 2017
Edited Transcript of MED earnings conference call or presentation 9-Mar-17 9:30pm GMT Mar 09 2017
Medifast posts 4Q profit Mar 09 2017
Medifast posts 4Q profit Mar 09 2017
MEDIFAST INC Files SEC form 8-K, Results of Operations and Financial Condition Mar 09 2017
Medifast, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results Mar 09 2017
10 Best Performing Weight Loss Companies And Their Programs Mar 09 2017
Q4 2016 Medifast Inc Earnings Release - After Market Close Mar 09 2017
Medifast, Inc. Announces Quarterly Dividend Mar 07 2017
MEDIFAST INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 07 2017
Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December... Feb 23 2017
Take Shape For Life® Hosts Largest Go Global Leadership Conference Ever Feb 20 2017
Medifast, Inc. – Value Analysis (NYSE:MED) : January 18, 2017 Jan 18 2017
ETFs with exposure to Medifast, Inc. : January 17, 2017 Jan 17 2017
Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : January 13, 2017 Jan 13 2017
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)